Trafalgar International (GCAN) Non-Current Debt (2020 - 2023)
Trafalgar International (GCAN) posted Non-Current Debt of $36000.0 for Q3 2023, down 73.33% on a QoQ basis from $135000.0 in Q3 2022, and down 73.33% year-over-year from $135000.0 in Q3 2022.
Analysis
Trafalgar International (GCAN) Non-Current Debt (2020 - 2023) Analysis & Trends
Trafalgar International has reported Non-Current Debt for 4 years, with the latest figure at $36000.0 in Q3 2023.
- On a quarterly basis, Non-Current Debt fell 73.33% year-over-year to $36000.0 in Q3 2023; TTM through Sep 2023 was $36000.0, a 73.33% decrease from a year earlier, with the FY2020 full-year figure at $325212.0, changed N/A from the prior year.
- Non-Current Debt was $36000.0 for Q3 2023 at Trafalgar International, down from $135000.0 in the prior quarter.
- The five-year high for Non-Current Debt was $325212.0 in Q4 2020, with the low at $22500.0 in Q1 2021.
- Average Non-Current Debt over 4 years is $146532.6, with a median of $101041.0 recorded in 2020.
- The largest YoY upside for Non-Current Debt was 0.0% in 2021 against a maximum downside of 86.39% in 2021.
- Over 4 years, Non-Current Debt stood at $325212.0 in 2020, then declined by 4.35% to $311050.0 in 2021, then plunged by 56.6% to $135000.0 in 2022, then plunged by 73.33% to $36000.0 in 2023.
- The last three Non-Current Debt figures came in at $36000.0 (Q3 2023), $135000.0 (Q3 2022), and $25000.0 (Q2 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 60.50 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 17.02 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 36,000.00 |
| Sep 30, 2022 | 135,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Sep 30, 2021 | 311,050.00 |
| Jun 30, 2021 | 67,082.00 |
| Mar 31, 2021 | 22,500.00 |
| Dec 31, 2020 | 325,212.00 |
| Sep 30, 2020 | 311,050.00 |
| Jun 30, 2020 | 67,082.00 |
| Mar 31, 2020 | 165,350.00 |